Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.

Nikolaisen, C; Kvien, T K; Mikkelsen, K; Kaufmann, C; Rødevand, E; Nossent, J C

Nikolaisen, C; Kvien, T K; Mikkelsen, K; Kaufmann, C; Rødevand, E; Nossent, J C.

Affiliation

Nikolaisen C; Department of Rheumatology at Institute of Clinical Medicine, University of Tromsø, Norway.

Scand J Rheumatol ; 38(4): 240-5, 2009.

Article in En | MEDLINE | ID: mdl-19229766

Subject(s)

Antirheumatic Agents/therapeutic use; Arthritis, Rheumatoid/diagnosis; Arthritis, Rheumatoid/drug therapy; Methotrexate/therapeutic use; Sulfasalazine/therapeutic use; Adult; Age Factors; Aged; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Early Diagnosis; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Norway; Odds Ratio; Pain Measurement; Probability; Risk Assessment; Sex Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Sulfasalazine / Methotrexate / Antirheumatic Agents Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Scand J Rheumatol Year: 2009 Document type: Article Affiliation country: Norway

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google